Search
for
Sort by
Research 481–510 of 1000+
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- Androgenetic alopecia as a cardiovascular risk factor
- OP-048 The Relation Between Androgenetic Alopecia and Cardiovascular Atherosclerosis Measured via Carotid Intima-Media Thickness and the SYNTAX Score
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- The relation between the severity of androgenetic alopecia and cardiovascular atherosclerosis measured via carotid intima-media thickness and the syntax score
- Male Androgenetic Alopecia and Cardiovascular Risk Factors
- Comorbidities in patients with androgenetic alopecia: cardiovascular risk factors and benign prostatic hyperplasia
- Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation
- The Cardiovascular Safety of Dutasteride
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia
- P326: Cardiovascular features in adult individuals affected with Tatton-Brown-Rahman syndrome
- 43303 Cardiovascular Risk in Patients with Scarring and Non-Scarring Alopecias: Assessing the Current State of Evidence
- Androgens and Cardiovascular Disease
- Repurposing of approved cardiovascular drugs
- Pathogenesis of Cardiovascular Alterations in Dogs Treated with Minoxidil
- Anabolic-androgenic steroids and cardiovascular risk
- Review of Cardiovascular Findings in Humans Treated with Minoxidil
- Male Androgenetic Alopecia and Cardiovascular Risk Factors: A Case-Control Study
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Dexpanthenol ameliorates lipopolysaccharide-induced cardiovascular toxicity by regulating the IL-6/HIF1α/VEGF pathway
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrhea
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology
- Cardiac and brainstem neuroinflammatory pathways account for androgenic incitement of cardiovascular and autonomic manifestations in endotoxic male rats
- Factores de riesgo cardiovascular en pacientes con alopecia androgenética: síndrome metabólico y ateromatosis carotidea
- Hair loss and cardiovascular health